Use of GABAA receptor modulators for treatment of itch
US11529359B2 · kind B2 · utility
0Cited by
11References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2020 |
| Grant date | Dec 20, 2022 |
| Priority date | — |
| Expiry date | Sep 8, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound for use in the treatment of itch is provided, wherein the compound comprises the general formula (1a), general formula (1b) or general formula (1c). The compounds of the invention are positive allosteric α2 and/or α3 GABAA receptor modulators.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.